SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: VLAD who wrote (10316)7/1/1998 3:39:00 PM
From: EyeDrMike  Read Replies (2) | Respond to of 23519
 
I also foresee supply problems for the product as international sales ramp up. Remember, even though many countries are MUSE approved, few actually have a rollout to date. When this occurs, will Vivus be able to handle demand?

I believe VVUS management foresees this as well, hence the new Ireland plant.

Mike



To: VLAD who wrote (10316)7/1/1998 4:43:00 PM
From: DaiS  Respond to of 23519
 
Vlad,

This point about Vivus being a one product company. A huge drug company that makes its money by selling a variety of pills that people put in their mouths and swallow could be said to be a one product company on this basis. Stretching an analogy a lot perhaps, but Vivus does have this patent on one hole in the human body, and with Alibra it does have > one pill. Does the incontinence treatment work with a similar pill - I don't know? What about treating other things through the penis? I don't know?

As Edderd said a couple of days back, we need some actor or celeb to say it ain't a great deal putting a pill in your penis. IMO for sure there will be better drugs and combinations to put in the penis for erections and other things - much better than putting it in the mouth and swallowing it and getting it all over the body, how crude and primitive.

DaiS